Thursday, June 26, 2008

Chantix: Poisoning the smoker

The FDA, earlier this year, issued a public safety advisory about Chantix, a pill that acts on the nicotine receptors in the brain, causing psychiatric symptoms including suicidal thoughts and suicidal tendencies. Since Chantix's approval in May 2006 until the end of December 2007, the FDA had received 227 domestic reports of suicidal acts, thoughts or behaviors, 397 cases of possible psychosis and 525 reports of hostility or aggression with many of the patients reporting hallucinations and thoughts of killing people. This also included 28 suicides. The FAA has band the use of Chantix for all pilots and air traffic controllers.
Included in every Phase trial of chemical replacement there is intense behavioral modification courses. Little mention of the effects on smokers from these courses is ever mentioned with regard to their efficacy as a stand alone program even though when no intervention is involved, all chemical smoke cessation products have low efficacy rates and potentially lethal and side-effects. Isn’t it time local, state, and federal governmental agencies along with leading universities and non-profit organizations cease to be the sales force for big Pharma and start looking at alternative cessation methods that have much higher efficacy rates with lower to no side-effects? The TobaccoB'Gone System is non-chemical safe and effective for both smoke cessation and relapse prevention carmelhypnosis@aol.com

No comments: